封面
市場調查報告書
商品編碼
1708130

傷口清潔產品市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Wound Cleanser Products Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: | 出版商: Global Market Insights Inc. | 英文 136 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球傷口清潔產品市場價值為 21 億美元,預計 2025 年至 2034 年期間的複合年成長率為 4.9%。隨著全球外科手術數量的增加,對傷口清潔產品的需求持續上升。這些產品旨在清潔傷口和周圍區域,有效去除可能導致感染的污垢和碎屑,同時促進更快癒合。糖尿病和血管疾病等慢性病的日益普及推動了對先進傷口護理解決方案的需求。此外,創傷、燒傷和壓瘡發病率的不斷上升進一步推動了醫院、診所和家庭醫療保健機構對傷口清潔產品的採用。

傷口清潔產品市場 - IMG1

醫療技術的進步也在塑造市場趨勢方面發揮了重要作用。微創手術的興起對支持術後恢復和預防併發症的傷口清潔劑的需求更高。製造商正專注於開發可提高功效和便利性的創新傷口護理解決方案,例如免沖洗清潔劑和抗菌配方。隨著醫療保健提供者強調感染預防和更好的患者治療結果,預計市場將在預測期內穩步擴張。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 21億美元
預測值 34億美元
複合年成長率 4.9%

市場根據產品類型分類,包括潤濕劑、防腐劑、保濕劑和脈衝沖洗系統。潤濕劑領域在 2024 年創造了 7.92 億美元的收入,成為慢性和急性傷口護理的重要組成部分。這些產品在穿透傷口和清除碎片方面非常有效,因此在各種醫療保健環境中都必不可少。潤濕劑有泡沫、噴霧和凝膠等形式,因其方便和有效而越來越受歡迎。持續的產品創新繼續推動該領域的需求,使潤濕劑成為傷口管理的首選。

從產品形態來看,傷口清潔產品市場分為噴霧劑、溶液、濕紙巾和其他形態。解決方案部分在 2024 年佔據了最大的市場佔有率,預計到 2034 年將達到 16 億美元。傷口清潔溶液,例如鹽水、防腐劑和基於酵素的配方,在深層清潔傷口、預防感染和加速癒合過程中發揮著至關重要的作用。這些產品廣泛應用於醫院、門診和家庭醫療保健環境,特別是用於治療慢性傷口、手術傷口和創傷性損傷。它們能夠提供有效的清潔和感染控制,使其成為全球醫療保健專業人士的首選。

2023 年,美國傷口清潔產品市場產值達到 5.845 億美元,這得益於大量選擇性手術(包括骨科和心血管手術)的推動。人口老化和慢性病盛行率的上升極大地促進了對先進傷口護理解決方案的需求。由於高度重視感染預防和更快的恢復,美國仍然是全球傷口清潔劑行業最突出的市場之一。

目錄

第1章:方法論與範圍

第2章:執行摘要

第3章:行業洞察

  • 產業生態系統分析
  • 產業衝擊力
    • 成長動力
      • 外科手術數量不斷增加
      • 糖尿病盛行率上升
      • 慢性病盛行率不斷上升
      • 傷口清潔產品的技術不斷進步
    • 產業陷阱與挑戰
      • 先進的傷口清潔產品成本高昂
  • 成長潛力分析
  • 監管格局
  • 技術格局
  • 未來市場趨勢
  • 差距分析
  • 波特的分析
  • PESTEL分析

第4章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 策略儀表板

第5章:市場估計與預測:依產品類型,2021 年至 2034 年

  • 主要趨勢
  • 潤濕劑
  • 防腐劑
  • 保濕霜
  • 脈衝沖洗系統
    • 一次性的
    • 可重複使用的

第6章:市場估計與預測:依形式,2021 年至 2034 年

  • 主要趨勢
  • 噴霧劑
  • 解決方案
  • 濕紙巾
  • 其他形式

第7章:市場估計與預測:按應用,2021 年至 2034 年

  • 主要趨勢
  • 急性傷口
  • 手術傷口
    • 外傷
    • 燒傷
  • 慢性傷口
    • 糖尿病足潰瘍
    • 壓瘡
    • 靜脈性腿部潰瘍
    • 其他慢性傷口

第8章:市場估計與預測:依最終用途,2021 年至 2034 年

  • 主要趨勢
  • 醫院
  • 專科診所
  • 居家照護環境
  • 其他最終用途

第9章:市場估計與預測:按地區,2021 年至 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國

第10章:公司簡介

  • 3M
  • Armis Biopharma
  • B. Braun
  • Biomiq
  • Cardinal Health
  • Coloplast
  • ConvaTec
  • HR HealthCare
  • Integra LifeSciences
  • Johnson & Johnson
  • Medline Industries
  • Med Scrub
  • Molnlycke Health Care
  • Smith + Nephew
  • Stryker
  • Urgo Medical
  • Zimmer Biomet
簡介目錄
Product Code: 13265

The Global Wound Cleanser Products Market was valued at USD 2.1 billion in 2024 and is projected to grow at a CAGR of 4.9% between 2025 and 2034. The demand for wound cleanser products continues to rise as the number of surgical procedures increases worldwide. These products are designed to clean wounds and surrounding areas, effectively removing dirt and debris that could lead to infections while also promoting faster healing. The growing prevalence of chronic conditions, such as diabetes and vascular diseases, has driven the need for advanced wound care solutions. Additionally, the increasing incidence of trauma cases, burns, and pressure ulcers has further fueled the adoption of wound cleanser products across hospitals, clinics, and home healthcare settings.

Wound Cleanser Products Market - IMG1

Advancements in medical technology have also played a significant role in shaping market trends. The rise of minimally invasive surgeries has created a higher demand for wound cleansers that support post-operative recovery and prevent complications. Manufacturers are focusing on developing innovative wound care solutions that enhance efficacy and convenience, such as no-rinse cleansers and antimicrobial formulations. With healthcare providers emphasizing infection prevention and better patient outcomes, the market is expected to witness steady expansion over the forecast period.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$2.1 Billion
Forecast Value$3.4 Billion
CAGR4.9%

The market is categorized based on product types, including wetting agents, antiseptics, moisturizers, and pulsed lavage systems. The wetting agents segment generated USD 792 million in 2024, emerging as a crucial component in both chronic and acute wound care. These products are highly effective at penetrating wounds and removing debris, making them essential across various healthcare settings. Available in foams, sprays, and gels, wetting agents are gaining traction due to their convenience and effectiveness. Ongoing product innovation continues to drive demand in this segment, positioning wetting agents as a top choice in wound management.

In terms of product form, the wound cleanser market is divided into sprays, solutions, wipes, and other forms. The solutions segment accounted for the largest share of the market in 2024 and is expected to reach USD 1.6 billion by 2034. Wound cleansing solutions, such as saline, antiseptics, and enzyme-based formulations, play a vital role in deep cleaning wounds, preventing infections, and accelerating the healing process. These products are widely used in hospitals, outpatient clinics, and home healthcare settings, particularly for treating chronic wounds, surgical wounds, and traumatic injuries. Their ability to provide effective cleansing and infection control makes them a preferred choice for healthcare professionals worldwide.

The U.S. wound cleanser products market generated USD 584.5 million in 2023, driven by the high volume of elective surgeries, including orthopedic and cardiovascular procedures. The aging population and the rising prevalence of chronic conditions have significantly contributed to the demand for advanced wound care solutions. With a strong focus on infection prevention and faster recovery, the U.S. remains one of the most prominent markets in the global wound cleanser industry.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing number of surgical procedures
      • 3.2.1.2 Rising prevalence of diabetes
      • 3.2.1.3 Increasing prevalence of chronic diseases
      • 3.2.1.4 Growing technological advancements in wound cleansing products
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with advance wound cleansing products
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Wetting agents
  • 5.3 Antiseptic
  • 5.4 Moisturizers
  • 5.5 Pulsed lavage systems
    • 5.5.1 Disposable
    • 5.5.2 Reusable

Chapter 6 Market Estimates and Forecast, By Form, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Sprays
  • 6.3 Solutions
  • 6.4 Wipes
  • 6.5 Other forms

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Acute wounds
  • 7.3 Surgical wounds
    • 7.3.1 Traumatic wounds
    • 7.3.2 Burns
  • 7.4 Chronic wounds
    • 7.4.1 Diabetic foot ulcers
    • 7.4.2 Pressure ulcers
    • 7.4.3 Venous leg ulcers
    • 7.4.4 Other chronic wounds

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Specialty clinics
  • 8.4 Home care settings
  • 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 3M
  • 10.2 Armis Biopharma
  • 10.3 B. Braun
  • 10.4 Biomiq
  • 10.5 Cardinal Health
  • 10.6 Coloplast
  • 10.7 ConvaTec
  • 10.8 HR HealthCare
  • 10.9 Integra LifeSciences
  • 10.10 Johnson & Johnson
  • 10.11 Medline Industries
  • 10.12 Med Scrub
  • 10.13 Molnlycke Health Care
  • 10.14 Smith + Nephew
  • 10.15 Stryker
  • 10.16 Urgo Medical
  • 10.17 Zimmer Biomet